{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:06:17Z","timestamp":1790784377857,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":149,"publisher":"Springer Nature Singapore","isbn-type":[{"value":"9789819901128","type":"print"},{"value":"9789819901135","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-99-0113-5_6","type":"book-chapter","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:23:23Z","timestamp":1678879403000},"page":"105-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pseudotyped Viruses for Marburgvirus and Ebolavirus"],"prefix":"10.1007","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/82_2017_7","volume":"411","author":"JH Kuhn","year":"2017","unstructured":"Kuhn, J.H.: Guide to the correct use of filoviral nomenclature. Curr. Top. Microbiol. Immunol. 411, 447\u2013460 (2017). https:\/\/doi.org\/10.1007\/82_2017_7","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41564-018-0328-y","volume":"4","author":"XL Yang","year":"2019","unstructured":"Yang, X.L., et al.: Characterization of a filovirus (Mengla virus) from Rousettus bats in China. Nat. Microbiol. 4, 390\u2013395 (2019). https:\/\/doi.org\/10.1038\/s41564-018-0328-y","journal-title":"Nat. Microbiol."},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s10393-020-01502-y","volume":"17","author":"J Euren","year":"2020","unstructured":"Euren, J., et al.: Human interactions with bat populations in Bombali, Sierra Leone. Ecohealth. 17, 292\u2013301 (2020). https:\/\/doi.org\/10.1007\/s10393-020-01502-y","journal-title":"Ecohealth"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41579-019-0233-2","volume":"17","author":"T Hoenen","year":"2019","unstructured":"Hoenen, T., Groseth, A., Feldmann, H.: Therapeutic strategies to target the Ebola virus life cycle. Nat. Rev. Microbiol. 17, 593\u2013606 (2019). https:\/\/doi.org\/10.1038\/s41579-019-0233-2","journal-title":"Nat. Rev. Microbiol."},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.3390\/v4101878","volume":"4","author":"K Brauburger","year":"2012","unstructured":"Brauburger, K., Hume, A.J., Muhlberger, E., Olejnik, J.: Forty-five years of Marburg virus research. Viruses. 4, 1878\u20131927 (2012). https:\/\/doi.org\/10.3390\/v4101878","journal-title":"Viruses"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1128\/jvi.68.9.6074-6078.1994","volume":"68","author":"T Horimoto","year":"1994","unstructured":"Horimoto, T., Nakayama, K., Smeekens, S.P., Kawaoka, Y.: Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J. Virol. 68, 6074\u20136078 (1994). https:\/\/doi.org\/10.1128\/jvi.68.9.6074-6078.1994","journal-title":"J. Virol."},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.3934\/mbe.2019155","volume":"16","author":"L Ponce","year":"2019","unstructured":"Ponce, L., Kinoshita, R., Nishiura, H.: Exploring the human-animal interface of Ebola virus disease outbreaks. Math. Biosci. Eng. 16, 3130\u20133143 (2019). https:\/\/doi.org\/10.3934\/mbe.2019155","journal-title":"Math. Biosci. Eng."},{"key":"6_CR8","first-page":"548","volume":"63","author":"MG Dixon","year":"2014","unstructured":"Dixon, M.G., Schafer, I.J., Centers for Disease, C. & Prevention: Ebola viral disease outbreak--West Africa, 2014. MMWR Morb. Mortal. Wkly Rep. 63, 548\u2013551 (2014)","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.3390\/v7102867","volume":"7","author":"SM Anthony","year":"2015","unstructured":"Anthony, S.M., Bradfute, S.B.: Filoviruses: one of these things is (not) like the other. Viruses. 7, 5172\u20135190 (2015). https:\/\/doi.org\/10.3390\/v7102867","journal-title":"Viruses"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1186\/s12879-016-2045-6","volume":"16","author":"L Nyakarahuka","year":"2016","unstructured":"Nyakarahuka, L., et al.: How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence. BMC Infect. Dis. 16, 708 (2016). https:\/\/doi.org\/10.1186\/s12879-016-2045-6","journal-title":"BMC Infect. Dis."},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.1999.0110","volume":"268","author":"VE Volchkov","year":"2000","unstructured":"Volchkov, V.E., et al.: Proteolytic processing of Marburg virus glycoprotein. Virology. 268, 1\u20136 (2000). https:\/\/doi.org\/10.1006\/viro.1999.0110","journal-title":"Virology"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/438575a","volume":"438","author":"EM Leroy","year":"2005","unstructured":"Leroy, E.M., et al.: Fruit bats as reservoirs of Ebola virus. Nature. 438, 575\u2013576 (2005). https:\/\/doi.org\/10.1038\/438575a","journal-title":"Nature"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mam.2007.09.005","volume":"29","author":"P Ascenzi","year":"2008","unstructured":"Ascenzi, P., et al.: Ebolavirus and Marburgvirus: insight the filoviridae family. Mol. Asp. Med. 29, 151\u2013185 (2008). https:\/\/doi.org\/10.1016\/j.mam.2007.09.005","journal-title":"Mol. Asp. Med."},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/82_2017_14","volume":"411","author":"RA Davey","year":"2017","unstructured":"Davey, R.A., et al.: Mechanisms of filovirus entry. Curr. Top. Microbiol. Immunol. 411, 323\u2013352 (2017). https:\/\/doi.org\/10.1007\/82_2017_14","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0168-1702(95)00080-1","volume":"39","author":"TW Geisbert","year":"1995","unstructured":"Geisbert, T.W., Jahrling, P.B.: Differentiation of filoviruses by electron microscopy. Virus Res. 39, 129\u2013150 (1995). https:\/\/doi.org\/10.1016\/0168-1702(95)00080-1","journal-title":"Virus Res."},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2016.09.001","volume":"135","author":"B Martin","year":"2016","unstructured":"Martin, B., Hoenen, T., Canard, B., Decroly, E.: Filovirus proteins for antiviral drug discovery: a structure\/function analysis of surface glycoproteins and virus entry. Antivir. Res. 135, 1\u201314 (2016). https:\/\/doi.org\/10.1016\/j.antiviral.2016.09.001","journal-title":"Antivir. Res."},{"key":"6_CR17","doi-asserted-by":"publisher","unstructured":"Gordon, T.B., Hayward, J.A., Marsh, G.A., Baker, M.L., Tachedjian, G.: Host and viral proteins modulating Ebola and Marburg virus egress. Viruses. 11 (2019). https:\/\/doi.org\/10.3390\/v11010025","DOI":"10.3390\/v11010025"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/bs.aivir.2017.12.002","volume":"100","author":"J Emanuel","year":"2018","unstructured":"Emanuel, J., Marzi, A., Feldmann, H.: Filoviruses: ecology, molecular biology, and evolution. Adv. Virus Res. 100, 189\u2013221 (2018). https:\/\/doi.org\/10.1016\/bs.aivir.2017.12.002","journal-title":"Adv. Virus Res."},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1073\/pnas.95.10.5762","volume":"95","author":"VE Volchkov","year":"1998","unstructured":"Volchkov, V.E., Feldmann, H., Volchkova, V.A., Klenk, H.D.: Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. U. S. A. 95, 5762\u20135767 (1998). https:\/\/doi.org\/10.1073\/pnas.95.10.5762","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1128\/JVI.02265-13","volume":"88","author":"J Maruyama","year":"2014","unstructured":"Maruyama, J., et al.: Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus. J. Virol. 88, 99\u2013109 (2014). https:\/\/doi.org\/10.1128\/JVI.02265-13","journal-title":"J. Virol."},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.virol.2006.06.041","volume":"358","author":"B Manicassamy","year":"2007","unstructured":"Manicassamy, B., et al.: Characterization of Marburg virus glycoprotein in viral entry. Virology. 358, 79\u201388 (2007). https:\/\/doi.org\/10.1016\/j.virol.2006.06.041","journal-title":"Virology"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature07082","volume":"454","author":"JE Lee","year":"2008","unstructured":"Lee, J.E., et al.: Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature. 454, 177\u2013182 (2008). https:\/\/doi.org\/10.1038\/nature07082","journal-title":"Nature"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1128\/JVI.02190-10","volume":"85","author":"M Mehedi","year":"2011","unstructured":"Mehedi, M., et al.: A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J. Virol. 85, 5406\u20135414 (2011). https:\/\/doi.org\/10.1128\/JVI.02190-10","journal-title":"J. Virol."},{"key":"6_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002304","volume":"7","author":"A Negredo","year":"2011","unstructured":"Negredo, A., et al.: Discovery of an ebolavirus-like filovirus in europe. PLoS Pathog. 7, e1002304 (2011). https:\/\/doi.org\/10.1371\/journal.ppat.1002304","journal-title":"PLoS Pathog."},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-3-030-67452-6_2","volume":"1313","author":"S Bhattacharyya","year":"2021","unstructured":"Bhattacharyya, S.: Mechanisms of immune evasion by Ebola virus. Adv. Exp. Med. Biol. 1313, 15\u201322 (2021). https:\/\/doi.org\/10.1007\/978-3-030-67452-6_2","journal-title":"Adv. Exp. Med. Biol."},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"12463","DOI":"10.1128\/jvi.76.24.12463-12472.2002","volume":"76","author":"SA Jeffers","year":"2002","unstructured":"Jeffers, S.A., Sanders, D.A., Sanchez, A.: Covalent modifications of the ebola virus glycoprotein. J. Virol. 76, 12463\u201312472 (2002). https:\/\/doi.org\/10.1128\/jvi.76.24.12463-12472.2002","journal-title":"J. Virol."},{"key":"6_CR27","doi-asserted-by":"publisher","unstructured":"Lennemann, N.J. et al.: Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. mBio 5, e00862\u201300813 (2014). https:\/\/doi.org\/10.1128\/mBio.00862-13","DOI":"10.1128\/mBio.00862-13"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1006\/viro.2000.0601","volume":"278","author":"A Takada","year":"2000","unstructured":"Takada, A., et al.: Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology. 278, 20\u201326 (2000). https:\/\/doi.org\/10.1006\/viro.2000.0601","journal-title":"Virology"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1073\/pnas.0807578106","volume":"106","author":"KL Schornberg","year":"2009","unstructured":"Schornberg, K.L., et al.: Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins. Proc. Natl. Acad. Sci. U. S. A. 106, 8003\u20138008 (2009). https:\/\/doi.org\/10.1073\/pnas.0807578106","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev-genom-083115-022446","volume":"17","author":"AL Rasmussen","year":"2016","unstructured":"Rasmussen, A.L.: Host factors in Ebola infection. Annu. Rev. Genomics Hum. Genet. 17, 333\u2013351 (2016). https:\/\/doi.org\/10.1146\/annurev-genom-083115-022446","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"Suppl 3","key":"6_CR31","doi-asserted-by":"publisher","first-page":"S957","DOI":"10.1093\/infdis\/jir326","volume":"204","author":"P Aleksandrowicz","year":"2011","unstructured":"Aleksandrowicz, P., et al.: Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J. Infect. Dis. 204(Suppl 3), S957\u2013S967 (2011). https:\/\/doi.org\/10.1093\/infdis\/jir326","journal-title":"J. Infect. Dis."},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature10348","volume":"477","author":"JE Carette","year":"2011","unstructured":"Carette, J.E., et al.: Ebola virus entry requires the cholesterol transporter Niemann-pick C1. Nature. 477, 340\u2013343 (2011). https:\/\/doi.org\/10.1038\/nature10348","journal-title":"Nature"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.coph.2021.06.008","volume":"60","author":"AR Sharma","year":"2021","unstructured":"Sharma, A.R., Lee, Y.H., Nath, S., Lee, S.S.: Recent developments and strategies of Ebola virus vaccines. Curr. Opin. Pharmacol. 60, 46\u201353 (2021). https:\/\/doi.org\/10.1016\/j.coph.2021.06.008","journal-title":"Curr. Opin. Pharmacol."},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/14760584.2019.1698952","volume":"18","author":"KM Matz","year":"2019","unstructured":"Matz, K.M., Marzi, A., Feldmann, H.: Ebola vaccine trials: progress in vaccine safety and immunogenicity. Expert Rev. Vaccines. 18, 1229\u20131242 (2019). https:\/\/doi.org\/10.1080\/14760584.2019.1698952","journal-title":"Expert Rev. Vaccines"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/S1473-3099(20)30282-6","volume":"20","author":"PL Iversen","year":"2020","unstructured":"Iversen, P.L., et al.: Recent successes in therapeutics for Ebola virus disease: no time for complacency. Lancet Infect. Dis. 20, e231\u2013e237 (2020). https:\/\/doi.org\/10.1016\/S1473-3099(20)30282-6","journal-title":"Lancet Infect. Dis."},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.coviro.2019.03.001","volume":"35","author":"MR Edwards","year":"2019","unstructured":"Edwards, M.R., Basler, C.F.: Current status of small molecule drug development for Ebola virus and other filoviruses. Curr. Opin. Virol. 35, 42\u201356 (2019). https:\/\/doi.org\/10.1016\/j.coviro.2019.03.001","journal-title":"Curr. Opin. Virol."},{"key":"6_CR37","unstructured":"Kerper, M., Puckett, Y.: In StatPearls (2022)"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-4939-7116-9_5","volume":"1628","author":"PL Sinn","year":"2017","unstructured":"Sinn, P.L., Coffin, J.E., Ayithan, N., Holt, K.H., Maury, W.: Lentiviral vectors Pseudotyped with filoviral glycoproteins. Methods Mol. Biol. 1628, 65\u201378 (2017). https:\/\/doi.org\/10.1007\/978-1-4939-7116-9_5","journal-title":"Methods Mol. Biol."},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4939-7116-9_4","volume":"1628","author":"RB Brouillette","year":"2017","unstructured":"Brouillette, R.B., Maury, W.: Production of filovirus glycoprotein-Pseudotyped vesicular stomatitis virus for study of filovirus entry mechanisms. Methods Mol. Biol. 1628, 53\u201363 (2017). https:\/\/doi.org\/10.1007\/978-1-4939-7116-9_4","journal-title":"Methods Mol. Biol."},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virol.2008.09.020","volume":"383","author":"Y Sun","year":"2009","unstructured":"Sun, Y., et al.: Protection against lethal challenge by Ebola virus-like particles produced in insect cells. Virology. 383, 12\u201321 (2009). https:\/\/doi.org\/10.1016\/j.virol.2008.09.020","journal-title":"Virology"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.antiviral.2011.06.003","volume":"91","author":"T Hoenen","year":"2011","unstructured":"Hoenen, T., Groseth, A., de Kok-Mercado, F., Kuhn, J.H., Wahl-Jensen, V.: Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antivir. Res. 91, 195\u2013208 (2011). https:\/\/doi.org\/10.1016\/j.antiviral.2011.06.003","journal-title":"Antivir. Res."},{"key":"6_CR42","doi-asserted-by":"publisher","unstructured":"Hoenen, T., Watt, A., Mora, A., Feldmann, H.: Modeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomes. J. Vis. Exp. 52381 (2014). https:\/\/doi.org\/10.3791\/52381","DOI":"10.3791\/52381"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1074\/jbc.M116.768168","volume":"292","author":"B Wang","year":"2017","unstructured":"Wang, B., et al.: Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function. J. Biol. Chem. 292, 5860\u20135870 (2017). https:\/\/doi.org\/10.1074\/jbc.M116.768168","journal-title":"J. Biol. Chem."},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"290ra289","DOI":"10.1126\/scitranslmed.aaa5597","volume":"7","author":"LM Johansen","year":"2015","unstructured":"Johansen, L.M., et al.: A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Sci. Transl. Med. 7, 290ra289 (2015). https:\/\/doi.org\/10.1126\/scitranslmed.aaa5597","journal-title":"Sci. Transl. Med."},{"key":"6_CR45","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1128\/JVI.01337-15","volume":"89","author":"H Cheng","year":"2015","unstructured":"Cheng, H., et al.: Inhibition of Ebola and Marburg virus entry by G protein-coupled receptor antagonists. J. Virol. 89, 9932\u20139938 (2015). https:\/\/doi.org\/10.1128\/JVI.01337-15","journal-title":"J. Virol."},{"key":"6_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.antiviral.2017.06.015","volume":"145","author":"H Cheng","year":"2017","unstructured":"Cheng, H., et al.: Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor. Antivir. Res. 145, 24\u201332 (2017). https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.015","journal-title":"Antivir. Res."},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3201\/eid2505.180115","volume":"25","author":"I Steffen","year":"2019","unstructured":"Steffen, I., et al.: Serologic prevalence of Ebola virus in equatorial Africa. Emerg. Infect. Dis. 25, 911\u2013918 (2019). https:\/\/doi.org\/10.3201\/eid2505.180115","journal-title":"Emerg. Infect. Dis."},{"key":"6_CR48","doi-asserted-by":"publisher","first-page":"10982","DOI":"10.1128\/JVI.01490-15","volume":"89","author":"E Davidson","year":"2015","unstructured":"Davidson, E., et al.: Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies. J. Virol. 89, 10982\u201310992 (2015). https:\/\/doi.org\/10.1128\/JVI.01490-15","journal-title":"J. Virol."},{"key":"6_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/infdis\/jix584","volume":"217","author":"AW Rimoin","year":"2018","unstructured":"Rimoin, A.W., et al.: Ebola virus neutralizing antibodies detectable in survivors of theYambuku, Zaire outbreak 40 years after infection. J. Infect. Dis. 217, 223\u2013231 (2018). https:\/\/doi.org\/10.1093\/infdis\/jix584","journal-title":"J. Infect. Dis."},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/infdis\/jiy453","volume":"218","author":"MS Bramble","year":"2018","unstructured":"Bramble, M.S., et al.: Pan-filovirus serum neutralizing antibodies in a subset of Congolese ebolavirus infection survivors. J. Infect. Dis. 218, 1929\u20131936 (2018). https:\/\/doi.org\/10.1093\/infdis\/jiy453","journal-title":"J. Infect. Dis."},{"key":"6_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.virol.2011.11.031","volume":"424","author":"K Gnirss","year":"2012","unstructured":"Gnirss, K., et al.: Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. Virology. 424, 3\u201310 (2012). https:\/\/doi.org\/10.1016\/j.virol.2011.11.031","journal-title":"Virology"},{"key":"6_CR52","doi-asserted-by":"publisher","unstructured":"Wu, F., et al.: A chimeric Sudan virus-like particle vaccine candidate produced by a recombinant baculovirus system induces specific immune responses in mice and horses. Viruses. 12 (2020). https:\/\/doi.org\/10.3390\/v12010064","DOI":"10.3390\/v12010064"},{"key":"6_CR53","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1016\/j.vaccine.2019.04.070","volume":"37","author":"L Xie","year":"2019","unstructured":"Xie, L., Zai, J., Yi, K., Li, Y.: Intranasal immunization with recombinant vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice. Vaccine. 37, 3335\u20133342 (2019). https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.070","journal-title":"Vaccine"},{"key":"6_CR54","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1128\/JVI.79.8.4793-4805.2005","volume":"79","author":"B Manicassamy","year":"2005","unstructured":"Manicassamy, B., Wang, J., Jiang, H., Rong, L.: Comprehensive analysis of ebola virus GP1 in viral entry. J. Virol. 79, 4793\u20134805 (2005). https:\/\/doi.org\/10.1128\/JVI.79.8.4793-4805.2005","journal-title":"J. Virol."},{"key":"6_CR55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12250-009-3015-6","volume":"24","author":"H Jiang","year":"2009","unstructured":"Jiang, H., et al.: The role of the charged residues of the GP2 helical regions in Ebola entry(). Virol. Sin. 24, 121\u2013135 (2009). https:\/\/doi.org\/10.1007\/s12250-009-3015-6","journal-title":"Virol. Sin."},{"key":"6_CR56","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1021\/jm1008715","volume":"54","author":"MV Yermolina","year":"2011","unstructured":"Yermolina, M.V., Wang, J., Caffrey, M., Rong, L.L., Wardrop, D.J.: Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry. J. Med. Chem. 54, 765\u2013781 (2011). https:\/\/doi.org\/10.1021\/jm1008715","journal-title":"J. Med. Chem."},{"key":"6_CR57","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1099\/vir.0.81199-0","volume":"86","author":"X Ji","year":"2005","unstructured":"Ji, X., et al.: Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J. Gen. Virol. 86, 2535\u20132542 (2005). https:\/\/doi.org\/10.1099\/vir.0.81199-0","journal-title":"J. Gen. Virol."},{"key":"6_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060838","volume":"8","author":"M Brudner","year":"2013","unstructured":"Brudner, M., et al.: Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors. PLoS One. 8, e60838 (2013). https:\/\/doi.org\/10.1371\/journal.pone.0060838","journal-title":"PLoS One"},{"key":"6_CR59","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.virusres.2015.12.019","volume":"213","author":"J Luczkowiak","year":"2016","unstructured":"Luczkowiak, J., et al.: Specific neutralizing response in plasma from convalescent patients of Ebola virus disease against the West Africa Makona variant of Ebola virus. Virus Res. 213, 224\u2013229 (2016). https:\/\/doi.org\/10.1016\/j.virusres.2015.12.019","journal-title":"Virus Res."},{"key":"6_CR60","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12250-011-3194-9","volume":"26","author":"J Wang","year":"2011","unstructured":"Wang, J., Manicassamy, B., Caffrey, M., Rong, L.: Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry. Virol. Sin. 26, 156\u2013170 (2011). https:\/\/doi.org\/10.1007\/s12250-011-3194-9","journal-title":"Virol. Sin."},{"key":"6_CR61","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1128\/jvi.74.10.4933-4937.2000","volume":"74","author":"SY Chan","year":"2000","unstructured":"Chan, S.Y., Speck, R.F., Ma, M.C., Goldsmith, M.A.: Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Virol. 74, 4933\u20134937 (2000). https:\/\/doi.org\/10.1128\/jvi.74.10.4933-4937.2000","journal-title":"J. Virol."},{"key":"6_CR62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/viro.2002.1730","volume":"305","author":"G Simmons","year":"2003","unstructured":"Simmons, G., et al.: DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology. 305, 115\u2013123 (2003). https:\/\/doi.org\/10.1006\/viro.2002.1730","journal-title":"Virology"},{"key":"6_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0092-8674(01)00418-4","volume":"106","author":"SY Chan","year":"2001","unstructured":"Chan, S.Y., et al.: Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell. 106, 117\u2013126 (2001). https:\/\/doi.org\/10.1016\/s0092-8674(01)00418-4","journal-title":"Cell"},{"key":"6_CR64","doi-asserted-by":"publisher","first-page":"13433","DOI":"10.1128\/jvi.77.24.13433-13438.2003","volume":"77","author":"G Simmons","year":"2003","unstructured":"Simmons, G., et al.: Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J. Virol. 77, 13433\u201313438 (2003). https:\/\/doi.org\/10.1128\/jvi.77.24.13433-13438.2003","journal-title":"J. Virol."},{"key":"6_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2018.04.020","volume":"155","author":"Q Li","year":"2018","unstructured":"Li, Q., et al.: Novel cyclo-peptides inhibit Ebola pseudotyped virus entry by targeting primed GP protein. Antivir. Res. 155, 1\u201311 (2018). https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.020","journal-title":"Antivir. Res."},{"key":"6_CR66","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1128\/JVI.79.2.918-926.2005","volume":"79","author":"A Yonezawa","year":"2005","unstructured":"Yonezawa, A., Cavrois, M., Greene, W.C.: Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J. Virol. 79, 918\u2013926 (2005). https:\/\/doi.org\/10.1128\/JVI.79.2.918-926.2005","journal-title":"J. Virol."},{"key":"6_CR67","doi-asserted-by":"publisher","first-page":"1088\u20131098 e1086","DOI":"10.1016\/j.cell.2016.10.014","volume":"167","author":"WE Diehl","year":"2016","unstructured":"Diehl, W.E., et al.: Ebola virus glycoprotein with increased infectivity dominated the 2013-2016 epidemic. Cell. 167, 1088\u20131098 e1086 (2016). https:\/\/doi.org\/10.1016\/j.cell.2016.10.014","journal-title":"Cell"},{"key":"6_CR68","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1080\/21645515.2017.1325050","volume":"13","author":"L Zhang","year":"2017","unstructured":"Zhang, L., et al.: A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system. Hum. Vaccin. Immunother. 13, 1811\u20131817 (2017). https:\/\/doi.org\/10.1080\/21645515.2017.1325050","journal-title":"Hum. Vaccin. Immunother."},{"key":"6_CR69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejmech.2018.02.061","volume":"149","author":"X Zhang","year":"2018","unstructured":"Zhang, X., et al.: Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage. Eur. J. Med. Chem. 149, 45\u201355 (2018). https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.061","journal-title":"Eur. J. Med. Chem."},{"key":"6_CR70","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12250-019-00184-3","volume":"35","author":"L Zhang","year":"2020","unstructured":"Zhang, L., et al.: Screening and identification of Marburg virus entry inhibitors using approved drugs. Virol. Sin. 35, 235\u2013239 (2020). https:\/\/doi.org\/10.1007\/s12250-019-00184-3","journal-title":"Virol. Sin."},{"key":"6_CR71","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41586-020-03146-y","volume":"590","author":"C Adaken","year":"2021","unstructured":"Adaken, C., et al.: Ebola virus antibody decay-stimulation in a high proportion of survivors. Nature. 590, 468\u2013472 (2021). https:\/\/doi.org\/10.1038\/s41586-020-03146-y","journal-title":"Nature"},{"key":"6_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1743-422X-6-75","volume":"6","author":"B Manicassamy","year":"2009","unstructured":"Manicassamy, B., Rong, L.: Expression of ebolavirus glycoprotein on the target cells enhances viral entry. Virol. J. 6, 75 (2009). https:\/\/doi.org\/10.1186\/1743-422X-6-75","journal-title":"Virol. J."},{"key":"6_CR73","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/85664","volume":"19","author":"GP Kobinger","year":"2001","unstructured":"Kobinger, G.P., Weiner, D.J., Yu, Q.C., Wilson, J.M.: Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19, 225\u2013230 (2001). https:\/\/doi.org\/10.1038\/85664","journal-title":"Nat. Biotechnol."},{"key":"6_CR74","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ymthe.2003.07.003","volume":"8","author":"MF Medina","year":"2003","unstructured":"Medina, M.F., et al.: Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol. Ther. 8, 777\u2013789 (2003). https:\/\/doi.org\/10.1016\/j.ymthe.2003.07.003","journal-title":"Mol. Ther."},{"key":"6_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030177","volume":"3","author":"NJ Sullivan","year":"2006","unstructured":"Sullivan, N.J., et al.: Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs. PLoS Med. 3, e177 (2006). https:\/\/doi.org\/10.1371\/journal.pmed.0030177","journal-title":"PLoS Med."},{"key":"6_CR76","doi-asserted-by":"publisher","unstructured":"Bentley, E.M., et al.: Cross-neutralisation of novel Bombali virus by Ebola virus antibodies and convalescent plasma using an optimised Pseudotype-based neutralisation assay. Trop Med Infect Dis. 6 (2021). https:\/\/doi.org\/10.3390\/tropicalmed6030155","DOI":"10.3390\/tropicalmed6030155"},{"issue":"Suppl 2","key":"6_CR77","doi-asserted-by":"publisher","first-page":"S259","DOI":"10.1086\/520594","volume":"196","author":"M Shimojima","year":"2007","unstructured":"Shimojima, M., Ikeda, Y., Kawaoka, Y.: The mechanism of Axl-mediated Ebola virus infection. J. Infect. Dis. 196(Suppl 2), S259\u2013S263 (2007). https:\/\/doi.org\/10.1086\/520594","journal-title":"J. Infect. Dis."},{"key":"6_CR78","doi-asserted-by":"publisher","first-page":"7702","DOI":"10.1128\/JVI.02433-06","volume":"81","author":"MA Brindley","year":"2007","unstructured":"Brindley, M.A., et al.: Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J. Virol. 81, 7702\u20137709 (2007). https:\/\/doi.org\/10.1128\/JVI.02433-06","journal-title":"J. Virol."},{"key":"6_CR79","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1128\/JVI.01278-09","volume":"85","author":"CL Hunt","year":"2011","unstructured":"Hunt, C.L., Kolokoltsov, A.A., Davey, R.A., Maury, W.: The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. J. Virol. 85, 334\u2013347 (2011). https:\/\/doi.org\/10.1128\/JVI.01278-09","journal-title":"J. Virol."},{"key":"6_CR80","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1182\/blood-2001-11-0042","volume":"100","author":"V Sandrin","year":"2002","unstructured":"Sandrin, V., et al.: Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood. 100, 823\u2013832 (2002). https:\/\/doi.org\/10.1182\/blood-2001-11-0042","journal-title":"Blood"},{"key":"6_CR81","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.chom.2017.02.002","volume":"21","author":"MK Wang","year":"2017","unstructured":"Wang, M.K., Lim, S.Y., Lee, S.M., Cunningham, J.M.: Biochemical basis for increased activity of Ebola glycoprotein in the 2013-16 epidemic. Cell Host Microbe. 21, 367\u2013375 (2017). https:\/\/doi.org\/10.1016\/j.chom.2017.02.002","journal-title":"Cell Host Microbe"},{"key":"6_CR82","doi-asserted-by":"publisher","first-page":"15951","DOI":"10.1074\/jbc.M601796200","volume":"281","author":"JH Kuhn","year":"2006","unstructured":"Kuhn, J.H., et al.: Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J. Biol. Chem. 281, 15951\u201315958 (2006). https:\/\/doi.org\/10.1074\/jbc.M601796200","journal-title":"J. Biol. Chem."},{"key":"6_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003232","volume":"9","author":"S Jemielity","year":"2013","unstructured":"Jemielity, S., et al.: TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog. 9, e1003232 (2013). https:\/\/doi.org\/10.1371\/journal.ppat.1003232","journal-title":"PLoS Pathog."},{"key":"6_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009275","volume":"17","author":"CM Stewart","year":"2021","unstructured":"Stewart, C.M., et al.: Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments. PLoS Pathog. 17, e1009275 (2021). https:\/\/doi.org\/10.1371\/journal.ppat.1009275","journal-title":"PLoS Pathog."},{"key":"6_CR85","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1128\/JVI.72.4.3155-3160.1998","volume":"72","author":"RJ Wool-Lewis","year":"1998","unstructured":"Wool-Lewis, R.J., Bates, P.: Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72, 3155\u20133160 (1998). https:\/\/doi.org\/10.1128\/JVI.72.4.3155-3160.1998","journal-title":"J. Virol."},{"key":"6_CR86","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.virusres.2006.06.002","volume":"121","author":"OM Mpanju","year":"2006","unstructured":"Mpanju, O.M., Towner, J.S., Dover, J.E., Nichol, S.T., Wilson, C.A.: Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry. Virus Res. 121, 205\u2013214 (2006). https:\/\/doi.org\/10.1016\/j.virusres.2006.06.002","journal-title":"Virus Res."},{"key":"6_CR87","doi-asserted-by":"publisher","first-page":"1079\u20131087 e1075","DOI":"10.1016\/j.cell.2016.10.013","volume":"167","author":"RA Urbanowicz","year":"2016","unstructured":"Urbanowicz, R.A., et al.: Human adaptation of Ebola virus during the west African outbreak. Cell. 167, 1079\u20131087 e1075 (2016). https:\/\/doi.org\/10.1016\/j.cell.2016.10.013","journal-title":"Cell"},{"key":"6_CR88","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.virol.2015.11.019","volume":"488","author":"C Miao","year":"2016","unstructured":"Miao, C., Li, M., Zheng, Y.M., Cohen, F.S., Liu, S.L.: Cell-cell contact promotes Ebola virus GP-mediated infection. Virology. 488, 202\u2013215 (2016). https:\/\/doi.org\/10.1016\/j.virol.2015.11.019","journal-title":"Virology"},{"key":"6_CR89","doi-asserted-by":"publisher","first-page":"10109","DOI":"10.1128\/JVI.01157-06","volume":"80","author":"M Shimojima","year":"2006","unstructured":"Shimojima, M., et al.: Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J. Virol. 80, 10109\u201310116 (2006). https:\/\/doi.org\/10.1128\/JVI.01157-06","journal-title":"J. Virol."},{"key":"6_CR90","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1073\/pnas.94.26.14764","volume":"94","author":"A Takada","year":"1997","unstructured":"Takada, A., et al.: A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 94, 14764\u201314769 (1997). https:\/\/doi.org\/10.1073\/pnas.94.26.14764","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"6_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149651","volume":"11","author":"M Hoffmann","year":"2016","unstructured":"Hoffmann, M., Gonzalez Hernandez, M., Berger, E., Marzi, A., Pohlmann, S.: The glycoproteins of all filovirus species use the same host factors for entry into bat and human cells but entry efficiency is species dependent. PLoS One. 11, e0149651 (2016). https:\/\/doi.org\/10.1371\/journal.pone.0149651","journal-title":"PLoS One"},{"key":"6_CR92","doi-asserted-by":"publisher","unstructured":"Hoffmann, M., et al.: A polymorphism within the internal fusion loop of the Ebola virus glycoprotein modulates host cell entry. J. Virol. 91 (2017). https:\/\/doi.org\/10.1128\/JVI.00177-17","DOI":"10.1128\/JVI.00177-17"},{"key":"6_CR93","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/gtc.12463","volume":"22","author":"MT Ueda","year":"2017","unstructured":"Ueda, M.T., et al.: Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency. Genes Cells. 22, 148\u2013159 (2017). https:\/\/doi.org\/10.1111\/gtc.12463","journal-title":"Genes Cells"},{"key":"6_CR94","doi-asserted-by":"publisher","first-page":"45552","DOI":"10.1038\/srep45552","volume":"7","author":"Q Liu","year":"2017","unstructured":"Liu, Q., et al.: Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection. Sci. Rep. 7, 45552 (2017). https:\/\/doi.org\/10.1038\/srep45552","journal-title":"Sci. Rep."},{"key":"6_CR95","doi-asserted-by":"publisher","first-page":"13397","DOI":"10.1128\/JVI.01820-12","volume":"86","author":"TJ Powell","year":"2012","unstructured":"Powell, T.J., Silk, J.D., Sharps, J., Fodor, E., Townsend, A.R.: Pseudotyped influenza a virus as a vaccine for the induction of heterotypic immunity. J. Virol. 86, 13397\u201313406 (2012). https:\/\/doi.org\/10.1128\/JVI.01820-12","journal-title":"J. Virol."},{"key":"6_CR96","doi-asserted-by":"publisher","unstructured":"Xiao, J.H., et al.: Characterization of influenza virus Pseudotyped with ebolavirus glycoprotein. J. Virol. 92 (2018). https:\/\/doi.org\/10.1128\/JVI.00941-17","DOI":"10.1128\/JVI.00941-17"},{"key":"6_CR97","doi-asserted-by":"publisher","first-page":"172\u2013186 e177","DOI":"10.1016\/j.celrep.2019.03.020","volume":"27","author":"P Rijal","year":"2019","unstructured":"Rijal, P., et al.: Therapeutic monoclonal antibodies for Ebola virus infection derived from vaccinated humans. Cell Rep. 27, 172\u2013186 e177 (2019). https:\/\/doi.org\/10.1016\/j.celrep.2019.03.020","journal-title":"Cell Rep."},{"key":"6_CR98","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1099\/jgv.0.000537","volume":"97","author":"RA Urbanowicz","year":"2016","unstructured":"Urbanowicz, R.A., et al.: Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay. J. Gen. Virol. 97, 2265\u20132279 (2016). https:\/\/doi.org\/10.1099\/jgv.0.000537","journal-title":"J. Gen. Virol."},{"key":"6_CR99","doi-asserted-by":"publisher","first-page":"14289","DOI":"10.1038\/s41598-020-71225-1","volume":"10","author":"K Steeds","year":"2020","unstructured":"Steeds, K., et al.: Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies. Sci. Rep. 10, 14289 (2020). https:\/\/doi.org\/10.1038\/s41598-020-71225-1","journal-title":"Sci. Rep."},{"key":"6_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jviromet.2018.01.003","volume":"254","author":"K Konduru","year":"2018","unstructured":"Konduru, K., Shurtleff, A.C., Bavari, S., Kaplan, G.: High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test. J. Virol. Methods. 254, 1\u20137 (2018). https:\/\/doi.org\/10.1016\/j.jviromet.2018.01.003","journal-title":"J. Virol. Methods"},{"key":"6_CR101","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1128\/JVI.00101-16","volume":"90","author":"PA Ilinykh","year":"2016","unstructured":"Ilinykh, P.A., et al.: Chimeric filoviruses for identification and characterization of monoclonal antibodies. J. Virol. 90, 3890\u20133901 (2016). https:\/\/doi.org\/10.1128\/JVI.00101-16","journal-title":"J. Virol."},{"key":"6_CR102","doi-asserted-by":"publisher","first-page":"S553","DOI":"10.1093\/infdis\/jiy316","volume":"218","author":"KL Warfield","year":"2018","unstructured":"Warfield, K.L., et al.: Role of antibodies in protection against Ebola virus in nonhuman primates immunized with three vaccine platforms. J. Infect. Dis. 218, S553\u2013S564 (2018). https:\/\/doi.org\/10.1093\/infdis\/jiy316","journal-title":"J. Infect. Dis."},{"key":"6_CR103","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3967\/bes2018.097","volume":"31","author":"R Yang","year":"2018","unstructured":"Yang, R., et al.: Neutralizing antibody Titer test of Ebola recombinant protein vaccine and gene vector vaccine pVR-GP-FC. Biomed. Environ. Sci. 31, 721\u2013728 (2018). https:\/\/doi.org\/10.3967\/bes2018.097","journal-title":"Biomed. Environ. Sci."},{"key":"6_CR104","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.antiviral.2017.08.011","volume":"146","author":"L Shuai","year":"2017","unstructured":"Shuai, L., et al.: Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs. Antivir. Res. 146, 36\u201344 (2017). https:\/\/doi.org\/10.1016\/j.antiviral.2017.08.011","journal-title":"Antivir. Res."},{"issue":"Suppl 1","key":"6_CR105","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1086\/514298","volume":"179","author":"K Mupapa","year":"1999","unstructured":"Mupapa, K., et al.: Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International scientific and technical committee. J. Infect. Dis. 179(Suppl 1), S18\u2013S23 (1999). https:\/\/doi.org\/10.1086\/514298","journal-title":"J. Infect. Dis."},{"key":"6_CR106","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1128\/JVI.75.10.4649-4654.2001","volume":"75","author":"M Gupta","year":"2001","unstructured":"Gupta, M., Mahanty, S., Bray, M., Ahmed, R., Rollin, P.E.: Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. J. Virol. 75, 4649\u20134654 (2001). https:\/\/doi.org\/10.1128\/JVI.75.10.4649-4654.2001","journal-title":"J. Virol."},{"key":"6_CR107","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-3-7091-7482-1_12","volume":"11","author":"PB Jahrling","year":"1996","unstructured":"Jahrling, P.B., et al.: Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch. Virol. Suppl. 11, 135\u2013140 (1996). https:\/\/doi.org\/10.1007\/978-3-7091-7482-1_12","journal-title":"Arch. Virol. Suppl."},{"key":"6_CR108","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1038\/srep06881","volume":"4","author":"J Audet","year":"2014","unstructured":"Audet, J., et al.: Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus. Sci. Rep. 4, 6881 (2014). https:\/\/doi.org\/10.1038\/srep06881","journal-title":"Sci. Rep."},{"key":"6_CR109","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41590-018-0233-9","volume":"19","author":"EO Saphire","year":"2018","unstructured":"Saphire, E.O., Schendel, S.L., Gunn, B.M., Milligan, J.C., Alter, G.: Antibody-mediated protection against Ebola virus. Nat. Immunol. 19, 1169\u20131178 (2018). https:\/\/doi.org\/10.1038\/s41590-018-0233-9","journal-title":"Nat. Immunol."},{"key":"6_CR110","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41467-018-08040-w","volume":"10","author":"JM Brannan","year":"2019","unstructured":"Brannan, J.M., et al.: Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates. Nat. Commun. 10, 105 (2019). https:\/\/doi.org\/10.1038\/s41467-018-08040-w","journal-title":"Nat. Commun."},{"key":"6_CR111","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2015.01.031","volume":"160","author":"AI Flyak","year":"2015","unstructured":"Flyak, A.I., et al.: Mechanism of human antibody-mediated neutralization of Marburg virus. Cell. 160, 893\u2013903 (2015). https:\/\/doi.org\/10.1016\/j.cell.2015.01.031","journal-title":"Cell"},{"key":"6_CR112","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.celrep.2016.04.026","volume":"15","author":"KA Howell","year":"2016","unstructured":"Howell, K.A., et al.: Antibody treatment of Ebola and Sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site. Cell Rep. 15, 1514\u20131526 (2016). https:\/\/doi.org\/10.1016\/j.celrep.2016.04.026","journal-title":"Cell Rep."},{"key":"6_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030009","volume":"3","author":"WB Oswald","year":"2007","unstructured":"Oswald, W.B., et al.: Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog. 3, e9 (2007). https:\/\/doi.org\/10.1371\/journal.ppat.0030009","journal-title":"PLoS Pathog."},{"key":"6_CR114","doi-asserted-by":"publisher","first-page":"976\u2013991 e911","DOI":"10.1016\/j.chom.2020.03.025","volume":"27","author":"PA Ilinykh","year":"2020","unstructured":"Ilinykh, P.A., et al.: Non-neutralizing antibodies from a Marburg infection survivor mediate protection by fc-effector functions and by enhancing efficacy of other antibodies. Cell Host Microbe. 27, 976\u2013991 e911 (2020). https:\/\/doi.org\/10.1016\/j.chom.2020.03.025","journal-title":"Cell Host Microbe"},{"key":"6_CR115","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1002\/cbic.201200493","volume":"13","author":"JF Koellhoffer","year":"2012","unstructured":"Koellhoffer, J.F., et al.: Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein. Chembiochem. 13, 2549\u20132557 (2012). https:\/\/doi.org\/10.1002\/cbic.201200493","journal-title":"Chembiochem"},{"key":"6_CR116","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1128\/JVI.75.5.2324-2330.2001","volume":"75","author":"A Takada","year":"2001","unstructured":"Takada, A., Watanabe, S., Okazaki, K., Kida, H., Kawaoka, Y.: Infectivity-enhancing antibodies to Ebola virus glycoprotein. J. Virol. 75, 2324\u20132330 (2001). https:\/\/doi.org\/10.1128\/JVI.75.5.2324-2330.2001","journal-title":"J. Virol."},{"issue":"Suppl 2","key":"6_CR117","doi-asserted-by":"publisher","first-page":"S347","DOI":"10.1086\/520581","volume":"196","author":"A Takada","year":"2007","unstructured":"Takada, A., Ebihara, H., Feldmann, H., Geisbert, T.W., Kawaoka, Y.: Epitopes required for antibody-dependent enhancement of Ebola virus infection. J. Infect. Dis. 196(Suppl 2), S347\u2013S356 (2007). https:\/\/doi.org\/10.1086\/520581","journal-title":"J. Infect. Dis."},{"issue":"Suppl 3","key":"6_CR118","doi-asserted-by":"publisher","first-page":"S978","DOI":"10.1093\/infdis\/jir334","volume":"204","author":"E Nakayama","year":"2011","unstructured":"Nakayama, E., et al.: Antibody-dependent enhancement of Marburg virus infection. J. Infect. Dis. 204(Suppl 3), S978\u2013S985 (2011). https:\/\/doi.org\/10.1093\/infdis\/jir334","journal-title":"J. Infect. Dis."},{"key":"6_CR119","doi-asserted-by":"publisher","first-page":"8907","DOI":"10.1128\/JVI.73.10.8907-8912.1999","volume":"73","author":"H Ito","year":"1999","unstructured":"Ito, H., Watanabe, S., Sanchez, A., Whitt, M.A., Kawaoka, Y.: Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J. Virol. 73, 8907\u20138912 (1999). https:\/\/doi.org\/10.1128\/JVI.73.10.8907-8912.1999","journal-title":"J. Virol."},{"issue":"Suppl 3","key":"6_CR120","doi-asserted-by":"publisher","first-page":"S897","DOI":"10.1093\/infdis\/jir313","volume":"204","author":"A Iwasa","year":"2011","unstructured":"Iwasa, A., Shimojima, M., Kawaoka, Y.: sGP serves as a structural protein in Ebola virus infection. J. Infect. Dis. 204(Suppl 3), S897\u2013S903 (2011). https:\/\/doi.org\/10.1093\/infdis\/jir313","journal-title":"J. Infect. Dis."},{"key":"6_CR121","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1128\/JVI.75.3.1576-1580.2001","volume":"75","author":"H Ito","year":"2001","unstructured":"Ito, H., Watanabe, S., Takada, A., Kawaoka, Y.: Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J. Virol. 75, 1576\u20131580 (2001). https:\/\/doi.org\/10.1128\/JVI.75.3.1576-1580.2001","journal-title":"J. Virol."},{"key":"6_CR122","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1110656","volume":"308","author":"K Chandran","year":"2005","unstructured":"Chandran, K., Sullivan, N.J., Felbor, U., Whelan, S.P., Cunningham, J.M.: Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science. 308, 1643\u20131645 (2005). https:\/\/doi.org\/10.1126\/science.1110656","journal-title":"Science"},{"key":"6_CR123","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","volume":"80","author":"K Schornberg","year":"2006","unstructured":"Schornberg, K., et al.: Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80, 4174\u20134178 (2006). https:\/\/doi.org\/10.1128\/JVI.80.8.4174-4178.2006","journal-title":"J. Virol."},{"key":"6_CR124","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.virol.2019.03.020","volume":"532","author":"M Gonzalez-Hernandez","year":"2019","unstructured":"Gonzalez-Hernandez, M., Muller, A., Hoenen, T., Hoffmann, M., Pohlmann, S.: Calu-3cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L. Virology. 532, 22\u201329 (2019). https:\/\/doi.org\/10.1016\/j.virol.2019.03.020","journal-title":"Virology"},{"key":"6_CR125","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/JVI.06346-11","volume":"86","author":"J Misasi","year":"2012","unstructured":"Misasi, J., et al.: Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J. Virol. 86, 3284\u20133292 (2012). https:\/\/doi.org\/10.1128\/JVI.06346-11","journal-title":"J. Virol."},{"key":"6_CR126","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1038\/emboj.2012.53","volume":"31","author":"EH Miller","year":"2012","unstructured":"Miller, E.H., et al.: Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 31, 1947\u20131960 (2012). https:\/\/doi.org\/10.1038\/emboj.2012.53","journal-title":"EMBO J."},{"key":"6_CR127","doi-asserted-by":"publisher","unstructured":"Bornholdt, Z.A. et al.: Host-primed Ebola virus GP exposes a hydrophobic NPC1 receptor-binding pocket, revealing a target for broadly neutralizing antibodies. mBio. 7, e02154\u201302115 (2016). https:\/\/doi.org\/10.1128\/mBio.02154-15","DOI":"10.1128\/mBio.02154-15"},{"key":"6_CR128","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1128\/JVI.01598-12","volume":"87","author":"O Martinez","year":"2013","unstructured":"Martinez, O., et al.: A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. J. Virol. 87, 3324\u20133334 (2013). https:\/\/doi.org\/10.1128\/JVI.01598-12","journal-title":"J. Virol."},{"key":"6_CR129","doi-asserted-by":"publisher","first-page":"e01857","DOI":"10.1128\/mBio.01857-15","volume":"7","author":"JS Spence","year":"2016","unstructured":"Spence, J.S., Krause, T.B., Mittler, E., Jangra, R.K., Chandran, K.: Direct visualization of Ebola virus fusion triggering in the endocytic pathway. MBio. 7, e01857\u2013e01815 (2016). https:\/\/doi.org\/10.1128\/mBio.01857-15","journal-title":"MBio"},{"key":"6_CR130","doi-asserted-by":"publisher","unstructured":"Mittler, E., Alkutkar, T., Jangra, R.K., Chandran, K.: Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligation. MBio. 12 (2021). https:\/\/doi.org\/10.1128\/mBio.03100-20","DOI":"10.1128\/mBio.03100-20"},{"key":"6_CR131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008900","volume":"16","author":"M Kuroda","year":"2020","unstructured":"Kuroda, M., Halfmann, P., Kawaoka, Y.: HER2-mediated enhancement of Ebola virus entry. PLoS Pathog. 16, e1008900 (2020). https:\/\/doi.org\/10.1371\/journal.ppat.1008900","journal-title":"PLoS Pathog."},{"key":"6_CR132","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1128\/JVI.00136-12","volume":"86","author":"ME Miller","year":"2012","unstructured":"Miller, M.E., Adhikary, S., Kolokoltsov, A.A., Davey, R.A.: Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection. J. Virol. 86, 7473\u20137483 (2012). https:\/\/doi.org\/10.1128\/JVI.00136-12","journal-title":"J. Virol."},{"key":"6_CR133","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1128\/jvi.76.13.6841-6844.2002","volume":"76","author":"CP Alvarez","year":"2002","unstructured":"Alvarez, C.P., et al.: C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76, 6841\u20136844 (2002). https:\/\/doi.org\/10.1128\/jvi.76.13.6841-6844.2002","journal-title":"J. Virol."},{"key":"6_CR134","doi-asserted-by":"publisher","unstructured":"Yu, C., et al.: MARCH8 inhibits Ebola virus glycoprotein, human immunodeficiency virus type 1 envelope glycoprotein, and avian influenza virus H5N1 hemagglutinin maturation. MBio. 11 (2020). https:\/\/doi.org\/10.1128\/mBio.01882-20","DOI":"10.1128\/mBio.01882-20"},{"key":"6_CR135","doi-asserted-by":"publisher","unstructured":"Stantchev, T.S., et al.: Cytokine effects on the entry of filovirus envelope Pseudotyped virus-like particles into primary human macrophages. Viruses. 11 (2019). https:\/\/doi.org\/10.3390\/v11100889","DOI":"10.3390\/v11100889"},{"key":"6_CR136","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbrc.2011.02.110","volume":"407","author":"K Usami","year":"2011","unstructured":"Usami, K., et al.: Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin. Biochem. Biophys. Res. Commun. 407, 74\u201378 (2011). https:\/\/doi.org\/10.1016\/j.bbrc.2011.02.110","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"6_CR137","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1038\/s41598-018-23357-8","volume":"8","author":"H Fujihira","year":"2018","unstructured":"Fujihira, H., et al.: A critical domain of ebolavirus envelope glycoprotein determines Glycoform and infectivity. Sci. Rep. 8, 5495 (2018). https:\/\/doi.org\/10.1038\/s41598-018-23357-8","journal-title":"Sci. Rep."},{"key":"6_CR138","doi-asserted-by":"publisher","unstructured":"Basu, A., Mills, D.M., Bowlin, T.L.: High-throughput screening of viral entry inhibitors using pseudotyped virus. Curr. Protoc. Pharmacol.. Chapter 13, Unit 13B 13. (2010). https:\/\/doi.org\/10.1002\/0471141755.ph13b03s51","DOI":"10.1002\/0471141755.ph13b03s51"},{"key":"6_CR139","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/jmv.24705","volume":"89","author":"Y Yang","year":"2017","unstructured":"Yang, Y., et al.: A cell-based high-throughput protocol to screen entry inhibitors of highly pathogenic viruses with traditional Chinese medicines. J. Med. Virol. 89, 908\u2013916 (2017). https:\/\/doi.org\/10.1002\/jmv.24705","journal-title":"J. Med. Virol."},{"key":"6_CR140","doi-asserted-by":"publisher","unstructured":"Cui, Q., et al.: Identification of ellagic acid from plant Rhodiola rosea L. as an anti-Ebola virus entry inhibitor. Viruses. 10 (2018). https:\/\/doi.org\/10.3390\/v10040152","DOI":"10.3390\/v10040152"},{"key":"6_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060579","volume":"8","author":"PB Madrid","year":"2013","unstructured":"Madrid, P.B., et al.: A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One. 8, e60579 (2013). https:\/\/doi.org\/10.1371\/journal.pone.0060579","journal-title":"PLoS One"},{"key":"6_CR142","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-4939-9940-8_12","volume":"2081","author":"S Lei","year":"2020","unstructured":"Lei, S., Huang, W., Wang, Y., Liu, Q.: In vivo bioluminescent imaging of Marburg virus in a rodent model. Methods Mol. Biol. 2081, 177\u2013190 (2020). https:\/\/doi.org\/10.1007\/978-1-4939-9940-8_12","journal-title":"Methods Mol. Biol."},{"key":"6_CR143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000003","volume":"16","author":"S Duffy","year":"2018","unstructured":"Duffy, S.: Why are RNA virus mutation rates so damn high? PLoS Biol. 16, e3000003 (2018). https:\/\/doi.org\/10.1371\/journal.pbio.3000003","journal-title":"PLoS Biol."},{"key":"6_CR144","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","volume":"182","author":"Q Li","year":"2020","unstructured":"Li, Q., et al.: The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell. 182, 1284\u20131294.e1289 (2020). https:\/\/doi.org\/10.1016\/j.cell.2020.07.012","journal-title":"Cell"},{"key":"6_CR145","doi-asserted-by":"publisher","unstructured":"Fels, J.M., et al.: A glycoprotein mutation that emerged during the 2013-2016 Ebola virus epidemic alters proteolysis and accelerates membrane fusion. MBio. 12 (2021). https:\/\/doi.org\/10.1128\/mBio.03616-20","DOI":"10.1128\/mBio.03616-20"},{"key":"6_CR146","doi-asserted-by":"publisher","unstructured":"Dietzel, E., Schudt, G., Krahling, V., Matrosovich, M., Becker, S.: Functional characterization of adaptive mutations during the west African Ebola virus outbreak. J. Virol. 91 (2017). https:\/\/doi.org\/10.1128\/JVI.01913-16","DOI":"10.1128\/JVI.01913-16"},{"key":"6_CR147","doi-asserted-by":"publisher","first-page":"11211","DOI":"10.1073\/pnas.1104760108","volume":"108","author":"SM Gregory","year":"2011","unstructured":"Gregory, S.M., et al.: Structure and function of the complete internal fusion loop from ebolavirus glycoprotein 2. Proc. Natl. Acad. Sci. U. S. A. 108, 11211\u201311216 (2011). https:\/\/doi.org\/10.1073\/pnas.1104760108","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"6_CR148","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1099\/jgv.0.000999","volume":"99","author":"Y Kurosaki","year":"2018","unstructured":"Kurosaki, Y., et al.: Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species. J. Gen. Virol. 99, 181\u2013186 (2018). https:\/\/doi.org\/10.1099\/jgv.0.000999","journal-title":"J. Gen. Virol."},{"key":"6_CR149","doi-asserted-by":"publisher","unstructured":"Banadyga, L., et al.: Atypical Ebola virus disease in a nonhuman primate following monoclonal antibody treatment is associated with glycoprotein mutations within the fusion loop. MBio. 12 (2021). https:\/\/doi.org\/10.1128\/mBio.01438-20","DOI":"10.1128\/mBio.01438-20"}],"container-title":["Advances in Experimental Medicine and Biology","Pseudotyped Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-99-0113-5_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:24:06Z","timestamp":1678879446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-99-0113-5_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9789819901128","9789819901135"],"references-count":149,"URL":"https:\/\/doi.org\/10.1007\/978-981-99-0113-5_6","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"16 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}